Maculopapular-type drug eruption caused by Coughcode(®)-N combination tablets.
Department of Dermatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan.
Chiharu
C
Yokose
Noriaki
N
Nakai
Norito
N
Katoh
D000082:Acetaminophen / Q000008:administration & dosage / Q000009:adverse effects*; D000284:Administration, Oral; D000293:Adolescent; D000996:Antitussive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001968:Bromisovalum / Q000008:administration & dosage / Q000009:adverse effects*; D003061:Codeine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D004155:Diphenhydramine / Q000008:administration & dosage / Q000009:adverse effects*; D004338:Drug Combinations; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology*; D004400:Dyphylline / Q000008:administration & dosage / Q000009:adverse effects*; D004804:Eosinophils / Q000276:immunology; D004809:Ephedrine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D007114:Immunization; D012882:Skin Tests; D013607:Tablets
D000996:Antitussive Agents; D004338:Drug Combinations; D013607:Tablets; C000589846:coughcode-N; D004400:Dyphylline; D000082:Acetaminophen; D001968:Bromisovalum; D004155:Diphenhydramine; D004809:Ephedrine; D003061:Codeine